TrialCardiology journal2022

Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor - NARCOTIC trial.

Piotr Niezgoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.